CSS LLC’s Immunomedics Inc IMMU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-3,000
Closed -$255K 1055
2020
Q3
$255K Buy
+3,000
New +$152K 0.01% 534
2019
Q1
Sell
-18,194
Closed -$260K 613
2018
Q4
$260K Hold
18,194
0.02% 360
2018
Q3
$379K Hold
18,194
0.02% 340
2018
Q2
$431K Sell
18,194
-4,000
-18% -$80.4K 0.02% 320
2018
Q1
$324K Buy
22,194
+5,000
+29% +$81.7K 0.02% 352
2017
Q4
$278K Buy
+17,194
New +$203K 0.01% 440
2017
Q3
Sell
-4,734
Closed -$47.2K 679
2017
Q2
$42K Buy
+4,734
New +$33.2K ﹤0.01% 607
2017
Q1
Sell
-22,009
Closed -$112K 770
2016
Q4
$81K Buy
22,009
+199
+0.9% +$589 ﹤0.01% 625
2016
Q3
$71K Sell
21,810
-10,000
-31% -$28K ﹤0.01% 663
2016
Q2
$74K Buy
+31,810
New +$106K ﹤0.01% 643

CSS LLC's IMMU Position: Q4 2020 in Review

CSS LLC sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 3,000 shares — an estimated $255K sold.

CSS LLC first reported a position in IMMU in Q2 2016 and held it in 10 quarters. The position peaked at $431K in Q2 2018. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • CSS LLC reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • CSS LLC sold 3,000 Immunomedics Inc shares in Q4 2020, an estimated $255K.
  • CSS LLC first reported a position in Immunomedics Inc in Q2 2016 and held it in 10 quarters.
  • CSS LLC's Immunomedics Inc position peaked at $431K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on CSS LLC's 13F filing for Q4 2020, filed 16 Feb 2021.